Page last updated: 2024-10-24

chloral hydrate and Psoriasis

chloral hydrate has been researched along with Psoriasis in 1 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research Excerpts

ExcerptRelevanceReference
"For lack of clinical safety data, preclinical tests for cutaneous cytotoxicity and calculations for systemic bioavailability after topical application have been performed."1.46[Preclinical safety evaluation of chloral hydrate after topical applicationĀ using the example of psoriatic itch]. ( Fischer, M; Gilbrich, F; Philipp, S; Wohlrab, J; Wolff, L, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wohlrab, J1
Gilbrich, F1
Wolff, L1
Fischer, M1
Philipp, S1

Other Studies

1 other study available for chloral hydrate and Psoriasis

ArticleYear
[Preclinical safety evaluation of chloral hydrate after topical applicationĀ using the example of psoriatic itch].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017, Volume: 68, Issue:3

    Topics: Administration, Cutaneous; Administration, Topical; Cell Line; Chloral Hydrate; Computer Simulation;

2017